Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.7 USD | -2.32% | +10.42% | +14.27% |
Mar. 15 | UBS Adjusts Cryoport Price Target to $17 From $14.50, Maintains Neutral Rating | MT |
Mar. 13 | Tranche Update on Cryoport, Inc.'s Equity Buyback Plan announced on March 11, 2022. | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company's enterprise value to sales, at 3.96 times its current sales, is high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Air Freight & Logistics
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.40% | 887M | C | ||
-18.51% | 6.03B | - | ||
+32.72% | 5.69B | - | ||
+14.46% | 4.06B | D | ||
+5.06% | 978M | - | - | |
+92.31% | 925M | B | ||
-10.08% | 610M | - | - | |
-20.77% | 558M | - | - | |
-6.76% | 451M | - | - | |
+30.00% | 415M | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock Cryoport, Inc. - Nasdaq
- Ratings Cryoport, Inc.